KMT2A oncoproteins induce epigenetic resistance to targeted therapies.

ABSTRACT: KMT2A oncoproteins induce epigenetic resistance to targeted therapies.

PROVIDER: PRJNA1060315 | ENA |

REPOSITORIES: ENA